These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27816557)

  • 1. Influence of magnesium supplementation on movement side effects related to typical antipsychotic treatment in rats.
    Kronbauer M; Metz VG; Roversi K; Dias VT; de David Antoniazzi CT; da Silva Barcelos RC; Burger ME
    Behav Brain Res; 2017 Mar; 320():400-411. PubMed ID: 27816557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances.
    Kronbauer M; Metz VG; Roversi K; Milanesi LH; Rubert Rossato D; da Silva Barcelos RC; Burger ME
    Behav Brain Res; 2019 Nov; 374():112119. PubMed ID: 31374223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters.
    Kronbauer M; Segat HJ; De David Antoniazzi CT; Roversi K; Roversi K; Pase CS; Barcelos RC; Burger ME
    Biol Trace Elem Res; 2015 Aug; 166(2):163-72. PubMed ID: 25686766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract.
    Trevizol F; Benvegnú DM; Barcelos RC; Pase CS; Segat HJ; Dias VT; Dolci GS; Boufleur N; Reckziegel P; Bürger ME
    Behav Brain Res; 2011 Aug; 221(1):13-8. PubMed ID: 21356248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
    Dhingra D; Goswami S; Gahalain N
    Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
    Macêdo DS; Oliveira GV; Gomes PX; Araújo FY; Souza CM; Vasconcelos SM; Viana GS; Sousa FC; Carvalho AF
    Behav Pharmacol; 2011 Oct; 22(7):674-80. PubMed ID: 21918383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Sonego AB; Gomes FV; Del Bel EA; Guimaraes FS
    Behav Brain Res; 2016 Aug; 309():22-8. PubMed ID: 27131780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.
    Barcelos RC; Benvegnú DM; Boufleur N; Reckziegel P; Müller LG; Pase C; Emanuelli T; Bürger ME
    Neurotox Res; 2010 Apr; 17(3):228-37. PubMed ID: 19644727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
    Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
    Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.
    Thaakur S; Himabindhu G
    J Neural Transm (Vienna); 2009 Jul; 116(7):807-14. PubMed ID: 19444377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
    Hyde TM; Egan MF; Wing LL; Wyatt RJ; Weinberger DR; Kleinman JE
    Psychopharmacology (Berl); 1995 Mar; 118(2):142-9. PubMed ID: 7617800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin Ameliorates Haloperidol-Induced Neurotoxicity and Orofacial Dyskinesia in a Rat Model of Human Tardive Dyskinesia.
    Wang MH; Yang CC; Tseng HC; Fang CH; Lin YW; Soung HS
    Neurotox Res; 2021 Jun; 39(3):774-786. PubMed ID: 33523404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
    Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.